Document Mentions (3 shared documents)

EFTA00136746

2 mentions1 same-page

Page ?Same page

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

i Al-Rasheed, American Enterprise Institute Resident Scholar Karen Young, Carnegie Endowment for International Peace Visiting Fellow Yasmine Farouk, Soufan Group Chairman and CEO Ali Soufan, and former U.S. Ambassador to Saudi Arabia Robert Jordan; 9:00 AM * CSIS online discussion with GOP Rep. Tom Cole on c

EFTA00148896

2 mentions1 same-page

Page ?Same page

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

Al-Rasheed, American Enterprise Institute Resident Scholar Karen Young, Carnegie Endowment for International Peace Visiting Fellow Yasmine Farouk, Soufan Group Chairman and CEO Ali Soufan, and former U.S. Ambassador to Saudi Arabia Robert Jordan; 9:00 AM • CSIS online discussion with GOP Rep. Tom Cole on c

EFTA01658495

2 mentions1 same-page

Page ?Same page

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

Mutual Connections (893)

Entities connected to both Amgen and Soufan Group

Jeffrey Epstein